Tamoxifen responders selection by computerized contact thermography in benign breast disease.
Initial thermic breast values recorded by contact thermography in 29 premenopausal patients with benign breast disease were compared to those recorded 4 and 24 hours after a single 20 mg tamoxifen oral administration. Programmes worked out by the thermographic Prometheus computerized system processed the thermic values. The data obtained were analyzed and compared to the clinical effects resulting from 2 or 3 tamoxifen therapeutic cycles subsequently administered to these patients. The results obtained so far are indicative of the possibility to differentiate by thermographic means the responders from non-responders to subsequent tamoxifen-therapy for breast benign disease.
D000232:Adenofibroma / Q000188:drug therapy; D000236:Adenoma / Q000188:drug therapy; D001943:Breast Neoplasms / Q000188:drug therapy*; D004334:Drug Administration Schedule; D001330:Electronic Data Processing; D005260:Female; D005348:Fibrocystic Breast Disease / Q000188:drug therapy*; D006801:Humans; D013629:Tamoxifen / Q000008:administration & dosage / Q000627:therapeutic use*; D013817:Thermography / Q000379:methods*
D013629:Tamoxifen